BEIJING, Nov. 18 (Xinhua) -- Subtle Medical, a well-known AI medical imaging company, recently completed its B-round financing of tens of millions of U.S. dollars, led by Eastern Bell Capital and co-led by Primavera Venture Partners, aiming to accelerate its layout in the Chinese market and raise its global presence, reported China Securities Journal Thursday.
Fusion Fund, Banyan Pacific Capital, European healthcare funds Crista Galli Ventures, Catchlight Capital and others investors also participated in the investment, among which most of the old shareholders made the additional investment.
The Subtle Medical has a product line of AI+ medical image enhancement accelerated products with its flagship products SubtlePET and SubtleMR, providing medical image AI solutions with cost reduction and efficiency improvement. Based on the global patented technology laid out since 2017, the company continues to expand its product line and market.
The company completed its A-round financing of 12.2 million U.S. dollars at the end of 2020 and achieved 400 percent revenue growth in 2021 year on year.
According to Subtle Medical, the company has completed clinical practice in more than 100 hospitals, imaging centers and physical examination centers in the Chinese market and has cooperated with more than 400 image service alliances and enterprises around the world, including RadNet, the largest image center alliance in the United States, and Affidea, the largest third-party inspection organization in Europe, etc.
The company will further develop the leading international technology, serve domestic and foreign customers, and accelerate the research and development of the multi-product matrix.
(Edited by Gao Jingyan with Xinhua Silk Road, gaojingyan@xinhua.org)
A single purchase
